PRCC Protein (Transcript Variant 1) (Myc-DYKDDDDK Tag)

Catalog No. ABIN2729557

This Recombinant PRCC protein is expressed in HEK-293 Cells.

Quick Overview for PRCC Protein (Transcript Variant 1) (Myc-DYKDDDDK Tag) (ABIN2729557)

Target: PRCC (Papillary Renal Cell Carcinoma (Translocation-Associated) (PRCC))

Protein Type: Recombinant

Origin: Human

Source: HEK-293 Cells

Application: Antibody Production (AbP), Standard (STD)

Purity: > 80 % as determined by SDS-PAGE and Coomassie blue staining

Product Details

Protein Characteristics: Transcript Variant 1

Purification tag / Conjugate: This PRCC protein is labelled with Myc-DYKDDDDK Tag.

Characteristics:

• Recombinant human PRCC (transcript variant 1) protein expressed in HEK293 cells.
• Produced with end-sequenced ORF clone

Application Details

Application Notes: Recombinant human proteins can be used for:
Native antigens for optimized antibody production
Positive controls in ELISA and other antibody assays

Comment:

The tag is located at the C-terminal.

Restrictions: For Research Use only

Handling

Concentration: 50 μg/mL

Buffer: 25 mM Tris.HCl, pH 7.3, 100 mM glycine, 10 % glycerol.

Storage: -80 °C

Storage Comment: Store at -80°C. Thaw on ice, aliquot to individual single-use tubes, and then re-freeze immediately. Only 2-3 freeze thaw cycles are recommended.

Target Details

Target: PRCC (Papillary Renal Cell Carcinoma (Translocation-Associated) (PRCC))

Alternative Name: Prcc

Background: This gene encodes a protein that may play a role in pre-mRNA splicing. Chromosomal translocations (X1)(p11q21) that result in fusion of this gene to TFE3 (GeneID 7030) have been associated with papillary renal cell carcinoma. A PRCC-TFE3 fusion protein is expressed in affected carcinomas and is likely associated with altered gene transactivation. This fusion protein has also been associated with disruption of the cell cycle.[provided by RefSeq, Aug 2010].

Molecular Weight: 52.2 kDa

NCBI Accession: NP_005964